SCHEMBL23833804

SCHEMBL23833804

CCOC(=O)C1(NC(=O)OC(C)(C)C)CC(O)C(F)C1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
DPP8 Q6V1X1 3/20 0.32
DPP9 Q86TI2 3/20 0.32
CYP1A2 P05177 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
HTT P42858 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA7 P43166 1/20 0.31
CA14 Q9ULX7 1/20 0.31
APLNR P35414 1/20 0.31
GHSR Q92847 1/20 0.30
CPB2 Q96IY4 1/20 0.30
CTSL P07711 1/20 0.30
LMNA P02545 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25492269 1.00 MEN1 (0.34) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL25492182 1.00 MEN1 (0.34) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL25492257 1.00 MEN1 (0.34) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL25492260 0.92 KMT2A (0.37) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL15306516 0.88 KMT2A (0.38) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL6886075 0.88 KMT2A (0.38) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL12173239 0.88 KMT2A (0.38) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL2362032 0.88 KMT2A (0.38) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL298008 0.85 KMT2A (0.38) MEN1KMT2AALDH1A1TSHRMAPK1
SCHEMBL10040060 0.85 KMT2A (0.38) MEN1KMT2AALDH1A1TSHRMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230158178-A1 Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof UNIV EMORY (US) 2023-05-25 US disclosed
EP-4121121-A1 RADIONUCLIDE TRACERS OF 1-AMINO-3,4-DIFLUOROCYCLOPENTANE-1-CARBOXYLIC ACID, DERIVATIVES, AND USES THEREOF Emory University (US) 2023-01-25 EP disclosed
WO-2021188592-A1 RADIONUCLIDE TRACERS OF 1-AMINO-3,4-DIFLUOROCYCLOPENTANE-1-CARBOXYLIC ACID, DERIVATIVES, AND USES THEREOF EMORY UNIVERSITY (US) 2021-09-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230158178-A1 Radionuclide Tracers of 1-Amino-3,4-Difluorocyclopentane-1-Carboxylic Acid, Derivatives, and Uses Thereof AFF1, METTL3, VHL MEN1 790/4885KMT2A 703/4885ALDH1A1 243/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.